Augmented Bone Graft Companies

Zimmer Biomet Holdings, Inc. (US) Launched the Vitoss® BoneAugment with Hyaluronic Acid as a pre-filled injectable bone substitute, offering enhanced osteoconductivity and ease of use for surgeons. Received FDA clearance for their Persona® Q+ Personalized 3D-Printed Titanium Spinal Systems, expanding their portfolio of patient-specific implants for bone fusion procedures.

Stryker Corporation (US) Partnered with BioMimetix to develop and commercialize next-generation biomimetic bone graft substitutes with bone-like properties for improved healing outcomes. Announced positive clinical results for their Osteocon® Nanocomposite Bone Putty, showcasing its efficacy in promoting bone growth and reducing healing time.

Medtronic (Ireland) Acquired K2M, a leading provider of spinal fusion technologies, strengthening their presence in the market and access to innovative bone graft substitutes. Partnered with universities to develop smart bone grafts with integrated sensors for real-time monitoring of healing progress and potential for optimizing procedures.

BioHorizons IPH, Inc. (US) Introduced the Mastergraft® Allograft with Osteoconductive Demineralized Bone Matrix, offering a convenient and effective option for surgeons seeking pre-hydrated and ready-to-use bone graft material. Collaborated with researchers to explore the potential of platelet-rich plasma (PRP) in combination with bone grafts for enhanced tissue regeneration and bone healing.

• Zimmer Holdings, Inc.


• BioMimetic Therapeutics LLC


• Wright Medical Technology, Inc.


• Stryker Corporation


• Smith & Nephew Plc


• RTI Surgical, Inc.


• Olympus Biotech Corporation


• NuVasive, Inc.


• NovaBone Products LLC


• Medtronic, Inc.


• LifeNet Health, Inc.


• Integra LifeSciences Holdings Corporation


• Exactech, Inc.


• DePuy Spine, Inc.


• Synthes Inc.


• DePuy Synthes Companies


• Biomet, Inc


• AlloSource